Browsing: leqvio

In a significant development, Novartis has launched a cutting-edge therapy designed to lower bad cholesterol levels, providing hope for patients at high risk of cardiovascular issues. This innovative treatment has the potential to dramatically improve the lives of those dealing with high cholesterol, a key risk factor for heart disease and stroke.

Hypercholesterolemia is well-established major risk factor for atherosclerotic cardiovascular disease (ASCVD), along with others including hypertension, diabetes mellitus, chronic kidney…